TRAP1 and Parkinson disease: Trap1, on the other hand, mitigates neurotoxicity induced by the human α-Synuclein protein [17] and addresses mitochondrial dysfunction, thereby rescuing neurodegeneration associated with Parkinson's disease (PD) [18].